Pharos Capital Acquires Sona MedSpa

We represented Pharos Capital Group, a private equity firm based in Dallas and Nashville, in its new dermatology platform investment, Maryland-based Dermatology and MedSpa, Inc., as well as its first add-on acquisition, Sona MedSpa. Sona is a leading North Carolina-based provider of cosmetic dermatology and medspa services throughout locations in several states. The terms of the transaction were not disclosed.

Based in Dallas and Nashville, Pharos Capital Group is a long-term, value-focused investor with approximately $800 million in assets under management. Pharos invests $25 million to $50 million for primarily majority positions in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations across the healthcare services sector.

You Also May Be Interested In:

  • Representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge with Strategic Storage Trust II, Inc., (SST II) in an all-cash merger valued at $340 million expected to close during the first quarter of 2019, subject to customary closing conditions, including the approval of SSGT’s stockholders

    We are representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge...
    Client Type: Private Company
  • Represented Wright Medical Group in its acquisition of Cartiva, Inc.

    We served as lead counsel to Wright Medical Group N.V. (Nasdaq: WMGI) in the acquisition of Cartiva, Inc., a privately-held...
    Client Type: Public Company
  • We represented NN, Inc. (Nasdaq: NNBR) in its public offering of 14,375,000 shares of common stock, which was composed of...
    Client Type: Public Company